Gulf Medical Projects Co.

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: AEG000401014
AED
2.00
0.04 (2.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Gulf Medical Projects Co. stock-summary
stock-summary
Gulf Medical Projects Co.
Hospital
Gulf Medical Projects Co PSC is a United Arab Emirates-based public shareholding company, which operates in the healthcare sector. The main activity of the Gulf Medical Projects Co PSC and its subsidiaries, together referred to as the Group, include general hospital, general clinic, import, hospital management, construction of medicine product factories, trading in medical equipment and its instruments, medicine and medical tools. The Company’s subsidiaries are: Al Zahra Pvt Hospital Dubai LLC, which operates as a general hospital and Al Zahra Neurosciences International LLC, which is engaged in investment in healthcare enterprises and development. The Company operates under the following segments: Health Services and Others, which is mainly providing health, medical care and other related services, as well as Investments, which is mainly concerned with investment properties and investment in securities.
Company Coordinates stock-summary
Company Details
S.B: 3499 , SHARJAH None : None
stock-summary
Tel: 971 6 5095555971 6 5168829
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
H.E. Sheikh Faisal Al Qassemi
Non-Independent Executive Chairman of the Board
Mr. Salem Al Hosani
Non-Independent Executive Vice Chairman of the Board
Sheikh Majed Al Qassimi
Non-Independent Executive Member of the Board, Managing Director
Mr. Abdullah Al Hosani
Non-Executive Non-Independent Member of the Board
Mr. Mohammed Al Hosani
Non-Executive Non-Independent Member of the Board
Sheikh Mohammed Al Qassimi
Non-Executive Non-Independent Member of the Board
Dr. Khalifa Al Jaber
Independent Member of the Board
Mr. Tareq Al Munser
Independent Member of the Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
180 Million
(Quarterly Results - Mar 2025)
Net Profit:
29 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

AED 1,433 Million (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

7.32%

stock-summary
Debt Equity

-0.20

stock-summary
Return on Equity

9.04%

stock-summary
Price to Book

1.26